Lara Marques

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 24

Top Topics

Molecular Docking

Breast Cancer Cells

Clinical Decision Support

Top Venues

Nanomaterials (Basel, Switzerland)

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eduarda Ribeiro, Bárbara Costa, Lara Marques, Francisco Vasques-Nóvoa, Nuno Vale
Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes. Journal of clinical medicine 13 (14) (2024)
Lara Marques, Nuno Vale
Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data. Pharmaceutics 16 (7) (2024)
Lara Marques, Nuno Vale
Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data. Pharmaceutics 16 (7) (2024)
Lara Marques, Bárbara Costa, Mariana Pereira, Abigail Silva, Joana Santos, Leonor Saldanha, Isabel Silva, Paulo Magalhães, Stephan Schmidt, Nuno Vale
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics 16 (3) (2024)
Lara Marques, Bárbara Costa, Mariana Pereira, Abigail Silva, Joana Santos, Leonor Saldanha, Isabel Silva, Paulo Magalhães, Stephan Schmidt, Nuno Vale
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics 16 (3) (2024)
Lara Marques, Bárbara Costa, Mariana Pereira, Abigail Silva, Joana Santos, Leonor Saldanha, Isabel Silva, Paulo Magalhães, Stephan Schmidt, Nuno Vale
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics 16 (3) (2024)
Eduarda Ribeiro, Bárbara Costa, Lara Marques, Francisco Vasques-Nóvoa, Nuno Vale
Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes. Journal of clinical medicine 13 (14) (2024)
Eduarda Ribeiro, Bárbara Costa, Lara Marques, Francisco Vasques-Nóvoa, Nuno Vale
Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes. Journal of clinical medicine 13 (14) (2024)
Lara Marques, Nuno Vale
Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data. Pharmaceutics 16 (7) (2024)
Ana Salomé Correia, Lara Marques, Nuno Vale
The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin. Current issues in molecular biology 45 (4) (2023)
Gonçalo de Jesus, Lara Marques, Nuno Vale, Rui Amaral Mendes
The Effects of Chitosan on the Healing Process of Oral Mucosa: An Observational Cohort Feasibility Split-Mouth Study. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Gonçalo de Jesus, Lara Marques, Nuno Vale, Rui Amaral Mendes
The Effects of Chitosan on the Healing Process of Oral Mucosa: An Observational Cohort Feasibility Split-Mouth Study. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Lara Marques, Nuno Vale
Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine. Pharmaceutics 15 (6) (2023)
Ana Salomé Correia, Lara Marques, Armando Cardoso, Nuno Vale
Exploring the Role of Drug Repurposing in Bridging the Hypoxia-Depression Connection. Membranes 13 (9) (2023)
Lara Marques, Nuno Vale
Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine. Pharmaceutics 15 (6) (2023)
Ana Salomé Correia, Lara Marques, Nuno Vale
The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin. Current issues in molecular biology 45 (4) (2023)
Gonçalo de Jesus, Lara Marques, Nuno Vale, Rui Amaral Mendes
The Effects of Chitosan on the Healing Process of Oral Mucosa: An Observational Cohort Feasibility Split-Mouth Study. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Gonçalo de Jesus, Lara Marques, Nuno Vale, Rui Amaral Mendes
The Effects of Chitosan on the Healing Process of Oral Mucosa: An Observational Cohort Feasibility Split-Mouth Study. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Lara Marques, Nuno Vale
Salbutamol in the Management of Asthma: A Review. International journal of molecular sciences 23 (22) (2022)
Nuno Vale, Mariana Pereira, Joana Santos, Catarina Moura, Lara Marques, Diana Duarte
Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches. International journal of molecular sciences 24 (1) (2022)
Nuno Vale, Mariana Pereira, Joana Santos, Catarina Moura, Lara Marques, Diana Duarte
Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches. International journal of molecular sciences 24 (1) (2022)
Rafaela Rodrigues, Lara Marques, Pedro Vieira Baptista, Carlos Sousa, Nuno Vale
Therapeutic Options for Chlamydia trachomatis Infection: Present and Future. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Nuno Vale, Mariana Pereira, Joana Santos, Catarina Moura, Lara Marques, Diana Duarte
Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches. International journal of molecular sciences 24 (1) (2022)
Lara Marques, Bárbara Costa, Nuno Vale
New Data for Nebivolol after In Silico PK Study: Focus on Young Patients and Dosage Regimen. Pharmaceutics 14 (9) (2022)